Canada markets closed

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.71-0.03 (-0.45%)
At close: 04:00PM EDT
6.85 +0.14 (+2.09%)
After hours: 06:11PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 463.75M
Enterprise Value 281.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)16.12
Price/Book (mrq)1.88
Enterprise Value/Revenue 13.54
Enterprise Value/EBITDA -2.20

Trading Information

Stock Price History

Beta (5Y Monthly) 3.19
52-Week Change 399.07%
S&P500 52-Week Change 322.38%
52 Week High 311.88
52 Week Low 31.06
50-Day Moving Average 38.38
200-Day Moving Average 34.70

Share Statistics

Avg Vol (3 month) 32.29M
Avg Vol (10 day) 31.17M
Shares Outstanding 568.81M
Implied Shares Outstanding 668.81M
Float 852.55M
% Held by Insiders 111.59%
% Held by Institutions 176.21%
Shares Short (Apr 15, 2024) 49.56M
Short Ratio (Apr 15, 2024) 44.55
Short % of Float (Apr 15, 2024) 419.77%
Short % of Shares Outstanding (Apr 15, 2024) 413.94%
Shares Short (prior month Mar 15, 2024) 45.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,147.71%

Management Effectiveness

Return on Assets (ttm)-21.53%
Return on Equity (ttm)-49.50%

Income Statement

Revenue (ttm)20.76M
Revenue Per Share (ttm)0.42
Quarterly Revenue Growth (yoy)14.30%
Gross Profit (ttm)N/A
EBITDA -137.15M
Net Income Avi to Common (ttm)-132.49M
Diluted EPS (ttm)-2.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)253.68M
Total Cash Per Share (mrq)3.7
Total Debt (mrq)70.98M
Total Debt/Equity (mrq)28.84%
Current Ratio (mrq)6.34
Book Value Per Share (mrq)4.07

Cash Flow Statement

Operating Cash Flow (ttm)-106.84M
Levered Free Cash Flow (ttm)-66.06M